AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NIH awards grant to develop new antibodies targeting SARS.
2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Diversa Corp. (DVSA) announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the company a grant for the discovery and development of antibodies to diagnose and treat Severe Acute Respiratory Syndrome (SARS).
Under the 3-year grant, Diversa will apply its OmniMab antibody program to screen more than 1 billion fully human antibodies against targets associated with the SARS-coronavirus. In collaboration with Diversa, the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) will then test antibody candidates selected and optimized by Diversa for their ability to neutralize live SARS-coronavirus. NIAID has recommended approximately $1.9 million in total funding, of which $1.0 million has been awarded for the first year of the project.
"A key benefit of Diversa's OmniMab antibody program is its ability to evolve 100% of all amino acids within the antibody protein, as well as its ability to access the over half of human antibodies that are typically ...
- Diversa Corporation to Announce Fourth Quarter and Full-Year Financial Results...
- Press release article from: Business Wire January 29, 2003 700+ words
...February 4, 2003 at 1:00 p.m. EST Diversa Corporation (Nasdaq:DVSA) today announced...February 3, 2003 after market close. Diversa will host a conference call with live...webcast by CCBN and can be accessed at Diversa's web site at http://www.diversa...
- Diversa Granted U.S. Patent Covering Technologies Directed To Discovery of...
- Press release article from: PR Newswire August 11, 2003 700+ words
Diversa Corporation today announced that it has...in this patent are an important part of Diversa's small molecule discovery platform...total microbial diversity. In contrast, Diversa's small molecule platform consists of...
- Diversa Receives Milestone Payments From Syngenta for Identification of Novel...
- Press release article from: PR Newswire September 14, 2004 700+ words
...Broad Collaboration Initiated in 2003 Diversa Corporation today announced that the company...payments of $300,000 from Syngenta. Diversa will begin early preclinical studies of...Syngenta, comprising multiple projects. "Diversa successfully identified these novel lead...
- Diversa Achieves Corporate Goals for 2001.
- Press release article from: PR Newswire December 21, 2001 700+ words
SAN DIEGO -- Diversa Corporation today announced the achievement of corporate goals for 2001. Diversa's corporate goals for the year included...and receiving issued patents. This year, Diversa signed four new deals, including one announced...
- Diversa Establishes Manufacturing Agreement for Enzyme Production With Fermic.
- Press release article from: PR Newswire February 23, 2004 700+ words
Diversa Corporation today announced that it has entered into...provide manufacturing capacity for the production of Diversa's enzyme products. Through this relationship, Diversa will increase its available manufacturing capacity to...
- Diversa Corporation to Present at BIO's Press Conference on the Science of...
- Press release article from: PR Newswire March 13, 2006 700+ words
...March 13 /PRNewswire-FirstCall/ -- Diversa Corporation will be presenting at the...in Washington, D.C. Paul Zorner, Diversa's Senior Director of Business Development...s recent State of the Union speech. Diversa's presentation will demonstrate the...
- Diversa and Syngenta Complete Transactions Announced in December.
- Press release article from: PR Newswire February 20, 2003 700+ words
Diversa Corporation today announced that it has...and product development alliance, and Diversa has acquired certain technology rights...At a special meeting held yesterday, Diversa stockholders approved the issuance to Syngenta...
- Diversa Corporation Ranked Among Top Places to Work in the Life Science...
- Press release article from: PR Newswire June 28, 2004 700+ words
Diversa Corporation announced today that the company was named...Executive Vice President of Internal Development at Diversa. "We clearly believe it is our people who have made Diversa a leader in the life science industry, and they deserve...
Source: HighBeam Research, NIH awards grant to develop new antibodies targeting SARS.